Inappropriate use of inhaled short acting beta-agonists and its association with patient health status
- PMID: 16393428
- DOI: 10.1185/030079905X74934
Inappropriate use of inhaled short acting beta-agonists and its association with patient health status
Abstract
Background: Despite the widespread distribution of guidelines on the proper use of inhaled asthma medication, the overuse of short acting bronchodilators (SABs) persists. This study aims to examine how inhaled asthma medications are used in the US and to examine whether inappropriate use of inhaled SABs is associated with poor patient health.
Research design and methods: The study design was a retrospective analysis of the Medical Expenditure Panel Survey (MEPS) for asthmatic patients 5 years or older who had used SAB medication during the period from 1996 through 2000. Use of SAB medication was defined as inappropriate when a patient inhaled more than 225 defined daily doses (DDDs) of SABs but less than 45.625 DDDs of corticosteroids per year. Health status was evaluated using survey respondents' perceptions on a 5-point Likert scale. Five functional limitations (activities of daily living, instrumental activities of daily living, walking, social function, and cognitive function) were rated on a dichotomous scale.
Results: A total of 2386 asthmatic patients were identified as having used a SAB in the period 1996 through 2000. Of these, 272 (11.4%) used excessive doses of SABs, and of this group of excessive users, 151 (55.5%) underused corticosteroids. Compared to appropriate users of SAB medication, inappropriate users had lower perceptions of their overall health (adjusted mean: 3.21 vs. 2.94, p<0.05) and mental health (adjusted mean: 2.39 vs. 2.13, p<0.05). They were also at an increased risk of limitations in walking (relative risk [RR]: 1.76, 95% confidence interval [CI]:1.15-2.71) and in cognitive function (RR: 2.32, 95% CI: 1.37-3.93).
Conclusion: Despite the national guidelines concerning the proper use of inhaled asthma medication, over-reliance on SAB medication and under-use of corticosteroids persists in the US. Those not using asthma medication according to the guidelines had poor perceptions of their health and were subject to an increased risk of limitations in walking and cognitive function.
Similar articles
-
Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.CMAJ. 2001 Mar 6;164(5):625-31. CMAJ. 2001. PMID: 11258208 Free PMC article.
-
Evidence for benefits of early intervention with non-steroidal drugs in asthma.Pediatr Pulmonol Suppl. 1997 Sep;15:34-9. Pediatr Pulmonol Suppl. 1997. PMID: 9316100 Review.
-
Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.Curr Med Res Opin. 2009 Sep;25(9):2251-8. doi: 10.1185/03007990903155915. Curr Med Res Opin. 2009. PMID: 19622006
-
Potential side effects in patients treated with inhaled corticosteroids and long-acting beta2-agonists.Respir Med. 2009 Apr;103(4):566-73. doi: 10.1016/j.rmed.2008.10.028. Epub 2009 Jan 10. Respir Med. 2009. PMID: 19136239
-
Controversies involving inhaled beta-agonists and inhaled corticosteroids in the treatment of asthma.Clin Chest Med. 1995 Dec;16(4):715-33. Clin Chest Med. 1995. PMID: 8565410 Review.
Cited by
-
Expert Consensus on SABA Use for Asthma Clinical Decision-Making: A Delphi Approach.Curr Allergy Asthma Rep. 2023 Nov;23(11):621-634. doi: 10.1007/s11882-023-01111-z. Epub 2023 Nov 22. Curr Allergy Asthma Rep. 2023. PMID: 37991672 Free PMC article. Review.
-
Asthma worsenings: approaches to prevention and management from the Asthma Worsenings Working Group.Can Respir J. 2008 Nov-Dec;15 Suppl B(Suppl B):1B-19B. doi: 10.1155/2008/973062. Can Respir J. 2008. PMID: 19129942 Free PMC article.
-
Factors associated with the appropriate use of asthma drugs.Can Respir J. 2011 Mar-Apr;18(2):97-104. doi: 10.1155/2011/426528. Can Respir J. 2011. PMID: 21499595 Free PMC article.
-
Predictors of inappropriate and excessive use of reliever medications in asthma: a 16-year population-based study.BMC Pulm Med. 2018 Feb 12;18(1):33. doi: 10.1186/s12890-018-0598-4. BMC Pulm Med. 2018. PMID: 29433489 Free PMC article.
-
Manifesto on the overuse of SABA in the management of asthma: new approaches and new strategies.Ther Adv Respir Dis. 2021 Jan-Dec;15:17534666211042534. doi: 10.1177/17534666211042534. Ther Adv Respir Dis. 2021. PMID: 34587829 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical